VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
GRDNGuardian Pharmacy Services, Inc.
$42.31$2.7B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksGRDNQuarterly Financials

Guardian Pharmacy Services, Inc. (GRDN) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Guardian Pharmacy Services, Inc. (GRDN) quarterly income statement — complete revenue, gross profit & net income history

GRDN Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q2'23Q1'23
Sales/Revenue336.6M397.62M377.43M344.33M329.31M338.57M314.39M300.04M275.41M281.07M253.44M248.95M
Revenue Growth %2.21%17.44%20.05%14.76%19.57%20.46%-18.39%10.63%18.65%--
Cost of Goods Sold260.29M322.79M302.71M276.19M264.96M271.46M253.51M238.75M220.31M226.49M203.12M197.73M
COGS % of Revenue77.33%81.18%80.2%80.21%80.46%80.18%80.64%79.57%79.99%80.58%80.14%79.43%
Gross Profit76.31M74.83M74.72M68.15M64.35M67.1M60.88M61.29M55.1M54.58M50.32M51.22M
Gross Margin %22.67%18.82%19.8%19.79%19.54%19.82%19.36%20.43%20.01%19.42%19.86%20.57%
Gross Profit Growth %18.59%11.51%22.74%11.19%16.78%22.95%-21.79%7.58%11.9%--
Operating Expenses58.63M27.85M58.37M55.57M51.34M50.35M165.49M44.28M47.17M39.05M25.03M44.76M
OpEx % of Revenue17.42%7%15.46%16.14%15.59%14.87%52.64%14.76%17.13%13.89%9.88%17.98%
Selling, General & Admin58.63M54.74M58.37M55.57M51.34M50.35M165.49M44.28M47.17M39.05M25.03M44.76M
SG&A % of Revenue17.42%13.77%15.46%16.14%15.59%14.87%52.64%14.76%17.13%13.89%9.88%17.98%
Research & Development000000000000
R&D % of Revenue------------
Other Operating Expenses0-1000K0000000000
Operating Income17.68M46.98M16.35M12.58M13.01M16.75M-104.61M17M7.93M15.52M25.3M6.46M
Operating Margin %5.25%11.81%4.33%3.65%3.95%4.95%-33.27%5.67%2.88%5.52%9.98%2.59%
Operating Income Growth %35.91%180.36%115.63%-26.02%63.94%7.93%--32.77%22.86%-3.4%--
EBITDA17.68M52.72M23.17M18.07M18.27M21.91M-99.62M16.91M12.68M20.24M29.72M10.91M
EBITDA Margin %5.25%13.26%6.14%5.25%5.55%6.47%-31.69%5.64%4.61%7.2%11.73%4.38%
EBITDA Growth %-3.27%140.62%123.26%6.83%44.06%8.25%--43.09%16.21%-0.33%--
D&A (Non-Cash Add-back)05.74M6.82M5.49M5.27M5.15M4.99M04.75M4.71M4.42M4.46M
EBIT17.68M36.6M16.79M12.76M13.28M16.64M-104.61M16.91M7.86M15.3M25.14M6.42M
Net Interest Income-154K-163K-160K-172K-170K-421K-1.03M-1.07M-765K-739K-702K-702K
Interest Income000000000000
Interest Expense154K163K160K172K170K421K1.03M1.07M765K739K702K702K
Other Income/Expense618K-15.88M277K7K101K-534K-1.03M-1.16M-838K-965K-853K-743K
Pretax Income18.29M31.1M16.63M12.59M13.11M16.22M-105.64M15.85M7.09M14.56M24.44M5.71M
Pretax Margin %5.43%7.82%4.41%3.66%3.98%4.79%-33.6%5.28%2.58%5.18%9.64%2.3%
Income Tax4.75M9.83M7.04M3.76M3.83M4.38M176K00000
Effective Tax Rate %25.96%31.62%42.32%29.87%29.25%27%-0.17%0%0%0%0%0%
Net Income13.29M20.92M9.82M9.03M9.45M11.94M-112.64M10.62M2.79M12.02M21.47M1.7M
Net Margin %3.95%5.26%2.6%2.62%2.87%3.53%-35.83%3.54%1.01%4.28%8.47%0.68%
Net Income Growth %40.72%75.19%108.72%-15%239.12%-0.62%--50.52%63.5%2.74%--
Net Income (Continuing)13.29M21.27M9.59M8.83M9.27M11.84M-105.82M15.85M7.09M14.56M24.44M5.71M
Discontinued Operations000000000000
Minority Interest11.53M12.16M11.74M10.11M7.13M7.3M6.33M39.34M031.65M32.77M34.45M
EPS (Diluted)0.210.330.150.140.150.20-2.000.17-0.140.380.350.03
EPS Growth %40%65%107.5%-17.65%207.14%-47.37%--51.43%-600%---
EPS (Basic)0.210.330.160.150.150.20-2.000.17-0.140.380.350.03
Diluted Shares Outstanding63.69M63.62M63.43M63.2M62.91M61.14M61.14M60.84M60.84M60.84M60.84M60.84M
Basic Shares Outstanding63.32M63.32M62.12M62.05M62.04M61.14M61.14M60.84M60.84M60.84M60.84M60.84M
Dividend Payout Ratio-----2.51%-156.36%255.92%83.21%73.24%361.85%